|
|
Volumn 4, Issue 5, 2002, Pages 415-418
|
|
National Heart, Lung, and Blood Institute of the National Institutes of Health forum on immune reconstitution and cellular therapy following hematopoietic stem-cell transplantation
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIGEN;
CD20 ANTIGEN;
INTERLEUKIN 7;
MYELOBLASTIN;
MYELOID SPECIFIC PROTEIN;
PEPTIDE VACCINE;
UNCLASSIFIED DRUG;
VACCINE;
VIRUS ANTIGEN;
VIRUS PROTEIN;
ADOPTIVE IMMUNOTHERAPY;
ALLOIMMUNITY;
ALLOTRANSPLANTATION;
B LYMPHOCYTE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CYTOTOXIC T LYMPHOCYTE;
DONOR;
DRUG EFFECT;
DRUG EFFICACY;
DRUG RESEARCH;
EPSTEIN BARR VIRUS;
FINANCIAL MANAGEMENT;
FOOD AND DRUG ADMINISTRATION;
GOOD MANUFACTURING PRACTICE;
GRAFT VERSUS HOST REACTION;
HEALTH CARE ORGANIZATION;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HLA MATCHING;
HOST;
HUMAN;
IMMUNE DEFICIENCY;
IMMUNITY;
IMMUNIZATION;
IMMUNOTHERAPY;
LEUKEMIA;
LUNG TOXICITY;
LYMPHOPROLIFERATIVE DISEASE;
MONOCYTE;
NONHUMAN;
QUALITY CONTROL;
RELAPSE;
SYMPOSIUM;
T LYMPHOCYTE;
TH2 CELL;
THYMUS FUNCTION;
UNITED STATES;
HEMATOPOIETIC STEM CELL;
IMMUNE SYSTEM;
IMMUNOLOGY;
LYMPHATIC SYSTEM DISEASE;
METHODOLOGY;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HEMATOPOIETIC STEM CELLS;
HUMANS;
IMMUNE SYSTEM;
IMMUNOTHERAPY;
LEUKEMIA;
LYMPHATIC DISEASES;
NATIONAL INSTITUTES OF HEALTH (U.S.);
UNITED STATES;
|
|
EID: 0036435234
PISSN: 14653249
EISSN: None
Source Type: Journal
DOI: 10.1080/146532402320776008 Document Type: Conference Paper |
|
Times cited : (6)
|
|
References (0)
|
